Skip to content
Medical Health Aged Care

Event Alert – Monday July 28 is World Hepatitis Day

Hepatitis Australia 2 mins read

MEDIA EVENT ALERT

Monday 28 July 2025 is World Hepatitis Day

World Hepatitis Day is a World Health Organisation (WHO) initiative to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease and liver cancer.

Hepatitis Australia coordinates the national World Hepatitis Day campaign each year, with each State and Territory Community Hepatitis Organisation taking part.

Hepatitis Australia invites media to attend and cover events marking World Hepatitis Day 2025 on and around Monday 28 July, as community organisations, and healthcare professionals unite to raise awareness and call for urgent action to eliminate viral hepatitis in Australia.

Chronic hepatitis B and C silently cause liver damage and cancer – despite them being preventable, treatable, and, in the case of hepatitis C, curable.

The campaign is a reminder that we must leave no one behind as we act now to expand access, integrate care, and end hepatitis as a public health problem by 2030.

National highlights include:

  • Official World Hepatitis Day Parliamentary Event – Hepatitis Australia will release national figures and policy priorities, calling on governments to accelerate progress toward elimination by 2030.
  • Liver Health Clinics and Testing Events – Free liver health checks, fibroscans, and hepatitis B and C testing clinics will take place in community settings across Australia.
  • Voices for Elimination – Peer workers, clinicians, and people with lived experience available for interview in many languages.
  • Landmarks Lit in Green – Iconic buildings around the country, including SA Parliament House and Hobart’s Tasman Bridge will light up green to increase awareness of the need to get tested.

Media Opportunities

  • Photo and interview opportunities with affected individuals, healthcare experts, and community leaders available in metro and regional locations.
  • Expert spokespeople from Hepatitis Australia

available for comment on:

    • Barriers to testing and treatment
    • The rising toll of liver cancer
    • Elimination progress and policy gaps

To arrange interviews or for more information, please contact:

Linda Apps 0433 999 017                                


Key Facts:

Hepatitis Australia coordinates the national World Hepatitis Day campaign each year, with each State and Territory Community Hepatitis Organisation taking part.

Hepatitis Australia invites media to attend and cover events marking World Hepatitis Day 2025 on and around Monday 28 July, as community organisations, and healthcare professionals unite to raise awareness and call for urgent action to eliminate viral hepatitis in Australia.

Chronic hepatitis B and C silently cause liver damage and cancer – despite them being preventable, treatable, and, in the case of hepatitis C, curable.

Anyone impacted by hepatitis B or C can be connected to community care, support and treatment by calling HepLink on 1800 437 222.


About us:

Hepatitis Australia, incorporated in 1997, is the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C. Our members are the eight state and territory hepatitis organisations.

Our Vision is to see an end to viral hepatitis in Australia.


Contact details:

Linda Apps 0433 999 017    

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.